Killing Anthrax More Quickly with Hot Air Decontamination
New method to decrease the amount of time it takes for hot air decontamination to kill bacterial spores, such as ...
New method to decrease the amount of time it takes for hot air decontamination to kill bacterial spores, such as ...
Elusys Therapeutics, which is being acquired by Heat Biologics, has finalized a contract with the U.S. Department of Health and Human Services ...
Scientists have demonstrated that modifying an enzyme produced by the bacterium that causes anthrax can protect mice from infection with ...
Study to enhance CDC’s capacity to rapidly detect emerging infectious disease agents To enhance the early detection of novel infectious ...
LexaGene will work with the U.S. Army Combat Capabilities Development Command (DEVCOM) Chemical Biological Center to demonstrate the capabilities of the ...
Like many U.S. research and development agencies, the Department of Homeland Security (DHS) Science and Technology Directorate (S&T) was forced to shift ...
In the United States, research and monitoring of airborne organisms is split between an array of federal agencies. The USDA ...
The Federal Select Agent Program dictates that all research entities in the United States must rigorously assess laboratory protocols to ...
A Malaysian scientist who recruited terrorists for Islamic State and al-Qaeda and tried to help Osama bin Laden develop anthrax for use ...
In mid-October 2019, the Indonesian police discovered that a cell of Jamaah Ansharud Daulah (JAD) – the largest pro-Islamic State (IS) network ...
A new report released this week by the Environmental Protection Agency’s Homeland Security Research program summarizes the results of decontamination ...
The Biomedical Advanced Research and Development Authority (BARDA) has exercised its first contract option with Emergent BioSolutions to procure doses ...
In a new study, researchers developed and evaluated a novel hexaplex PCR assay for simultaneous detection of pathogenic B. anthracis and Y. pestis as ...
Spero Therapeutics, Inc. today announced that it was awarded funding of $15.7 million, with the potential for up to an additional $28.5 ...
Following the October 2001 confirmation of anthrax in official government mail, a series of screening processes were implemented to safeguard ...
The U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) will ...
The Biomedical Advanced Research and Development Authority (BARDA) has awarded funding to Tangen BioSciences for advanced development of the company’s ...
The Biomedical Advanced Research and Development Authority (BARDA) is soliciting proposals for the advanced research and development of medical countermeasures ...
Elusys Therapeutics, Inc. announced today that the company has delivered the first doses of ANTHIM® (obiltoxaximab) Injection, its treatment for ...
The Defense Biological Product Assurance Office (DBPAO), a component of the Joint Program Executive Office for Chemical and Biological Defense, ...